First up is $AMRS, back in the beginning of August 2016 I came across Amyris @ $.37-$.39 range. Which I then reviewed the most recent 10Q’s & listened to the conference call where I heard lots of bullish signals. I would say its one of the most perfect squeezing patterns I’ve been able to spot before the breakout even occurred.
Second up is $APRI, this traded all over the place in June – October. It took some time to develop since any biotech’s in phases 1-3 of FDA approval have major hiccups to beaware of. Luckily I was anticipating APRI to get FDA approval since they were already selling and certified in Europe and other nations. I called bottom for members in our chat in the $1.10-$1.25 range. I Noted on 1/6/17 that any positive FDA news should send this flying back above 1/18/17 APRI gets VITAROS approved stock pops to $4. POP and DROP…. Sell on the news its almost like reverse logic sometimes since you never really know what the company is going to do. A month or 2 later APRI sold the rights of VITAROS… to ferring so the magic sauce that kept APRI hot and in-play was now subtracted.